Tarmogen® Technology Platform Creates Powerful, Targeted Immune Response to Diseased Cells and Drives Family of Oncology-Focused Products LOUISVILLE, Colo. & SUMMIT, N.J. – May 15, 2009 – GlobeImmune, Inc. and Celgene Corporation (NASDAQ: CELG) today announced a worldwide strategic collaboration … Continue reading
GlobeImmune and Celgene Corporation Announce Strategic Global Oncology Alliance
May 15, 2009